iBio
IBIO
IBIO
37 hedge funds and large institutions have $990K invested in iBio in 2022 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
30% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 20
80% less capital invested
Capital invested by funds: $4.97M → $990K (-$3.98M)
Holders
37
Holding in Top 10
–
Calls
$167K
Puts
$10K
Top Buyers
| 1 | +$218K | |
| 2 | +$147K | |
| 3 | +$49.8K | |
| 4 |
Two Sigma Investments
New York
|
+$23.8K |
| 5 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
+$22.2K |
Top Sellers
| 1 | -$142K | |
| 2 | -$33K | |
| 3 | -$31K | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$27K |
| 5 |
Bank of New York Mellon
New York
|
-$22K |